KeyBank at ViVE 2023
Over the past few years, we have seen more and more banks at healthcare conferences. It’s not surprising when you consider how important receiving and managing payments is to healthcare providers and health IT…
Continue Reading
Tag: payments
Weekly Roundup – April 8, 2023
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives…
Continue Reading
Payments, Price Transparency, GIS + EMS Response Times & Vendor Management at ViVE2023
At the recent ViVE2023 event we had the opportunity to sit down with industry leaders to discuss a number of important technologies, challenges, and opportunities. Check out the following interviews with KeyBank, Clarify Health,…
Continue Reading
Solve.Care Launches Decentralized Layer-2 Healthcare Blockchain Infrastructure
What You Should Know:Solve.Care, a healthcare platform company that leverages blockchain technology to deliver better care, has announced the launch of Care.Chain, a decentralized Layer-2 network infrastructure.Care.Chain is a significant step towards Solve.Care’s mission…
Continue Reading
Study Indicates Site-Neutral Payments May Pose a Risk to Healthcare Access
Site-neutral payments for medical services could impact the most vulnerable patients, according to a study by the American Hospital Association. Site-neutral payments reimburse medical providers the same amount regardless of whether a patient receives…
Continue Reading
FL Children’s Health Insurance Site Contractor Pays Fine to Resolve False Claims Act Allegations
By Jill McKeon March 17, 2023 – Jelly Bean Communications Design LLC, a Florida-based design firm, agreed to pay $293,771 to resolve False Claims Act allegations related to cybersecurity failures, the Department of Justice (DOJ)…
Continue Reading
Pfizer’s Migraine Drug Approval Triggers $475M Payment to Royalty Pharma
FDA approval of Pfizer nasal spray migraine drug Zavzpret last week means a $475 million payday for Royalty Pharma. The payment stems from a financing deal Pfizer inherited when it acquired rights to the…
Continue Reading